RXi Pharmaceuticals Awarded $580K in NIH Grants to Advance RNAi Therapeutics

RXi Pharmaceuticals Corporation RXII today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health .
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!